Double‐blind, placebo‐controlled pilot study of adjunctive quetiapine SR in the treatment of PMS/PMDD

Abstract

This small double-blind study suggests that adjunctive treatment with quetiapine SR may be a useful addition to selective serotonin reuptake inhibitor therapy in women with PMS/PMDD by reducing symptoms and improving quality of life.